Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ · Healthcare
Whitehawk Therapeutics, Inc. Operating Income 2018–2025
Whitehawk Therapeutics, Inc. annual/quarterly operating income history and growth rate from 2018 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Whitehawk Therapeutics, Inc. operating income for the quarter ending March 31, 2026 was -23.5 M, a 54.57% increase year-over-year.
- Whitehawk Therapeutics, Inc. operating income for the twelve months ending March 31, 2026 was -113.0 M, a 70.34% increase year-over-year.
- Whitehawk Therapeutics, Inc. annual operating income for 2025 was -114.4 M, a 69.59% increase from 2024.
- Whitehawk Therapeutics, Inc. annual operating income for 2024 was -67.5 M, a 6.22% decrease from 2023.
- Whitehawk Therapeutics, Inc. annual operating income for 2023 was -71.9 M, a 14.76% increase from 2022.
- Whitehawk Therapeutics, Inc. annual operating income for 2022 was -62.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Whitehawk Therapeutics, Inc. Operating Income — FAQ
Whitehawk Therapeutics, Inc. (WHWK) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Whitehawk Therapeutics, Inc.'s operating income?
Whitehawk Therapeutics, Inc. (WHWK) reported operating income of -$114M for fiscal 2025.
Where can I see WHWK's operating income history?
The chart and table above show Whitehawk Therapeutics, Inc.'s operating income by year and by quarter, including the growth rate.